The U.S. Food and Drug Administration (FDA) granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations to rezafungin for the...
Aspergillus
New test could screen patients at risk of Aspergillosis
A new study published in Nature Communications reports the discovery of a genetic mutation in humans linked to a 17-fold increase in the number of dan...
Guideline for management of Aspergillosis
Aspergillus species continue to be an important cause of life-threatening infection in immunocompromised patients. This at-risk population is comprise...
Elevated tissue iron a risk factor for Aspergillus Infection in lung transplant recipients
Dr.Mark Nicolls, Stanford University Professor in Pulmonary and Critical Care Medicine conducted a study to investigate why lung transplant patients ...
Terbinafine is first choice oral drug for fungal toenail infection
The oral antifungal drug terbinafine appears to be slightly better than alternative ‘azole’ drugs for treating fungal toenail infection. Fifty-eight p...
